Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.
about
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderThe Causative Classification of Stroke system: an international reliability and optimization studyThe feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application.Advances in the diagnosis of etiologic subtypes of ischemic stroke.Approximation of total visceral adipose tissue with a single magnetic resonance imageA multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.Reliability of the adult myopathy assessment tool in individuals with myositisWhy do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?Visceral adipose tissue: relations between single-slice areas and total volume.A single MRI slice does not accurately predict visceral and subcutaneous adipose tissue changes during weight lossA structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trialsAlzheimer's disease drug development in 2008 and beyond: problems and opportunitiesWeb-based training and interrater reliability testing for scoring the Hamilton Depression Rating Scale.Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?Estimating whole body intermuscular adipose tissue from single cross-sectional magnetic resonance imagesReliability of a questionnaire on substance use among adolescent students, Brazil.Adolescent substance-use assessment: methodological issues in the use of the ADAD (Adolescent Drug Abuse Diagnosis).Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.Reliability of infarct volumetry: Its relevance and the improvement by a software-assisted approach.A comparison of seminar and computer based training on the accuracy and reliability of raters using the Children's Global Assessment Scale (CGAS).
P2860
Q28079932-67EDB832-B34C-44B7-9C73-7EB70E7629A3Q30430386-F4A64DBF-F984-405E-BB43-33C4D75E9995Q33439138-DCD2B9F1-0086-4B86-BB98-B8D37D5A9237Q33819164-09A32329-85F8-4811-84EE-465EADEDAC73Q33904279-36A8AED3-B1C5-42A4-BE21-9A6D119DF068Q35172772-B85652A9-05D7-4D11-AC6C-096115DFBB88Q35669132-F88397AD-5267-442C-BA65-4C29152DED11Q36022784-C2C8DD64-4BA0-470C-9C26-692879D0F75DQ36088200-ECD7FCC6-84AA-41CE-A2EB-636935BF50B7Q36303566-F00964CB-5BD8-4637-9B7A-B9A57A410AC3Q36588803-7885D8DD-B035-4338-87D8-F016A6E5DBCAQ36942970-BF1DEA14-26DA-4258-B989-FED9439C14CFQ36990318-0FFBFFF8-1FE6-47C9-963A-15E76F399DA9Q37055784-24C51F7D-9B1C-4BE5-A2AD-6951AD21B436Q37379793-8B0D348B-DF21-49B0-B3A7-EC3BB1A70839Q39952619-80E36C5F-F033-4226-AEC0-B1BF36A674BCQ46389315-24445545-B9BE-449E-AA97-DFD82F8E1B2DQ46621227-FEB36CB8-8D13-4D2D-94F2-450A617D64D0Q48409685-4406D592-76CC-4558-8B15-901B814497CFQ50789525-4749417B-C12D-4213-81B2-E37414F81B00
P2860
Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of interrater reliabil ...... lculations in clinical trials.
@en
Effects of interrater reliabil ...... lculations in clinical trials.
@nl
type
label
Effects of interrater reliabil ...... lculations in clinical trials.
@en
Effects of interrater reliabil ...... lculations in clinical trials.
@nl
prefLabel
Effects of interrater reliabil ...... lculations in clinical trials.
@en
Effects of interrater reliabil ...... lculations in clinical trials.
@nl
P1476
Effects of interrater reliabil ...... lculations in clinical trials.
@en
P2093
Armin Szegedi
Matthias J Müller
P304
P356
10.1097/00004714-200206000-00013
P407
P577
2002-06-01T00:00:00Z